{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:45:27Z","timestamp":1781325927296,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1109626"],"award-info":[{"award-number":["1109626"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1060407"],"award-info":[{"award-number":["1060407"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1094304"],"award-info":[{"award-number":["1094304"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3811-5","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T05:30:27Z","timestamp":1546061427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3065-7495","authenticated-orcid":false,"given":"Jonathan","family":"Brett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam G.","family":"Elshaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"issue":"4","key":"3811_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5694\/mja14.01664","volume":"203","author":"I Scott","year":"2015","unstructured":"Scott I, Duckett S. In search of professional consensus in defining and reducing low-value care. Med J Aust. 2015;203(4):179\u201381.","journal-title":"Med J Aust"},{"issue":"14","key":"3811_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.2013.285362","volume":"311","author":"C Gliwa","year":"2014","unstructured":"Gliwa C, Pearson SD. Evidentiary rationales for the choosing wisely top 5 lists. J Am Med Assoc. 2014;311(14):1443\u20134.","journal-title":"J Am Med Assoc"},{"issue":"4","key":"3811_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMp0911423","volume":"362","author":"H Brody","year":"2010","unstructured":"Brody H. Medicine\u2019s ethical responsibility for health care reform\u2014the top five list. N Engl J Med. 2010;362(4):283\u20135.","journal-title":"N Engl J Med"},{"key":"3811_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bmjqs-2014-003821","volume":"24","author":"W Levinson","year":"2015","unstructured":"Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA, Burgers J, Cucic C, Daniels M, Forde I. \u2018Choosing wisely\u2019: a growing international campaign. BMJ Qual Saf. 2015;24:167\u201374.","journal-title":"BMJ Qual Saf"},{"issue":"7","key":"3811_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamainternmed.2014.1541","volume":"174","author":"AL Schwartz","year":"2014","unstructured":"Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014;174(7):1067\u201376.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"3811_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13012-017-0585-9","volume":"12","author":"J Brett","year":"2017","unstructured":"Brett J, Elshaug AG, Bhatia RS, Chalmers K, Badgery-Parker T, Pearson S-A. A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study. Implement Sci. 2017;12(1):58.","journal-title":"Implement Sci"},{"key":"3811_CR7","unstructured":"Australian Atlas of Healthcare Variation. 2015. \n                    http:\/\/www.safetyandquality.gov.au\/atlas\/\n                    \n                  . [Accessed Jan 2018]."},{"issue":"1","key":"3811_CR8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s13104-015-1616-8","volume":"8","author":"L Mellish","year":"2015","unstructured":"Mellish L, Karanges EA, Litchfield MJ, Schaffer AL, Blanch B, Daniels BJ, Segrave A, Pearson S-A. The Australian pharmaceutical benefits scheme data collection: a practical guide for researchers. BMC Res Notes. 2015;8(1):634.","journal-title":"BMC Res Notes"},{"key":"3811_CR9","unstructured":"ATC\/DDD Index 2018. \n                    https:\/\/www.whocc.no\/atc_ddd_index\/\n                    \n                  . [Accessed Jan 2018]."},{"issue":"11","key":"3811_CR10","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1111\/bcp.13369","volume":"83","author":"J Brett","year":"2017","unstructured":"Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, McLachlan AJ, Pearson SA. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. Br J Clin Pharmacol. 2017;83(11):2581\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3811_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/pds.3609","volume":"23","author":"E Leckman-Westin","year":"2014","unstructured":"Leckman-Westin E, Kealey E, Gupta N, Chen Q, Gerhard T, Crystal S, Olfson M, Finnerty M. Validation of a claims-based antipsychotic polypharmacy measure. Pharmacoepidemiol Drug Saf. 2014;23(6):628\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3811_CR12","unstructured":"ABS.STAT. \n                    http:\/\/stat.data.abs.gov.au\/Index.aspx?DataSetCode=ERP_QUARTERLY\n                    \n                  . Accessed Jan 2018."},{"key":"3811_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/bmjqs-2017-006678","volume":"26","author":"K Chalmers","year":"2017","unstructured":"Chalmers K, Pearson S-A, Elshaug AG. Quantifying low-value care: a patient-centric versus service-centric lens. BMJ Qual Saf. 2017;26:855\u20138.","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"3811_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1753-6405.2009.00357.x","volume":"33","author":"A Vitry","year":"2009","unstructured":"Vitry A, Wong SA, Roughead EE, Ramsay E, Barratt J. Validity of medication-based co-morbidity indices in the Australian elderly population. Aust N Z J Public Health. 2009;33(2):126\u201330.","journal-title":"Aust N Z J Public Health"},{"issue":"12","key":"3811_CR15","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction. 2011;106(12):2086\u2013109.","journal-title":"Addiction"},{"issue":"12","key":"3811_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2165\/00002512-200623120-00002","volume":"23","author":"P Gareri","year":"2006","unstructured":"Gareri P, De Fazio P, De Fazio S, Marigliano N, Ibbadu GF, De Sarro G. Adverse effects of atypical antipsychotics in the elderly. Drugs Aging. 2006;23(12):937\u201356.","journal-title":"Drugs Aging"},{"issue":"4","key":"3811_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1517\/14740338.2012.683523","volume":"11","author":"JA Gallego","year":"2012","unstructured":"Gallego JA, Nielsen J, De Hert M, Kane JM, Correll CU. Safety and tolerability of antipsychotic polypharmacy. Expert Opin Drug Saf. 2012;11(4):527\u201342.","journal-title":"Expert Opin Drug Saf"},{"key":"3811_CR18","unstructured":"National Prescribing Service MedicineWise. 2018. \n                    https:\/\/www.nps.org.au\/\n                    \n                  . [Accessed Jan 2018]."},{"key":"3811_CR19","unstructured":"Choosing Wisely Australia. 2018. \n                    http:\/\/www.choosingwisely.org.au\/\n                    \n                  . [Accessed Jan 2018]."},{"issue":"12","key":"3811_CR20","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/jgs.14379","volume":"64","author":"DT Maust","year":"2016","unstructured":"Maust DT, Kales HC, Wiechers IR, Blow FC, Olfson M. No end in sight: benzodiazepine use in older adults in the United States. J Am Geriatr Soc. 2016;64(12):2546\u201353.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3811_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"CM Campanelli","year":"2012","unstructured":"Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc. 2012;60(4):616.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3811_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5414\/CPP46072","volume":"46","author":"P Gallagher","year":"2008","unstructured":"Gallagher P, Ryan C, Byrne S, Kennedy J, O\u2019Mahony D. STOPP (Screening Tool of Older Person\u2019s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72\u201383.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"3811_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11606-014-3070-z","volume":"30","author":"CH Colla","year":"2015","unstructured":"Colla CH, Morden NE, Sequist TD, Schpero WL, Rosenthal MB. Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2015;30(2):221\u20138.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"3811_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-244X-12-155","volume":"12","author":"A Child","year":"2012","unstructured":"Child A, Clarke A, Fox C, Maidment I. A pharmacy led program to review anti-psychotic prescribing for people with dementia. BMC Psychiatry. 2012;12(1):155.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"3811_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","volume":"57","author":"PA Routledge","year":"2004","unstructured":"Routledge PA, O\u2019Mahony M, Woodhouse K. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"3811_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, Rubin HR. Why don't physicians follow clinical practice guidelines?: a framework for improvement. J Am Med Assoc. 1999;282(15):1458\u201365.","journal-title":"J Am Med Assoc"},{"issue":"2","key":"3811_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5694\/mja12.11593","volume":"198","author":"SN Hilmer","year":"2013","unstructured":"Hilmer SN, Gnjidic D. Rethinking psychotropics in nursing homes. Med J Aust. 2013;198(2):77.","journal-title":"Med J Aust"},{"issue":"3","key":"3811_CR28","doi-asserted-by":"publisher","first-page":"e010279","DOI":"10.1136\/bmjopen-2015-010279","volume":"6","author":"ID Maidment","year":"2016","unstructured":"Maidment ID, Shaw RL, Killick K, Damery S, Hilton A, Wilcock J, et al. Improving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy\u2013health psychology intervention feasibility study. BMJ Open. 2016;6(3):e010279.","journal-title":"BMJ Open"},{"issue":"4","key":"3811_CR29","doi-asserted-by":"publisher","first-page":"e013800","DOI":"10.1136\/bmjopen-2016-013800","volume":"7","author":"N Ailabouni","year":"2017","unstructured":"Ailabouni N, Mangin D, Nishtala PS. Deprescribing anticholinergic and sedative medicines: protocol for a feasibility trial (DEFEAT-polypharmacy) in residential aged care facilities. BMJ Open. 2017;7(4):e013800.","journal-title":"BMJ Open"},{"issue":"3","key":"3811_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/pds.1899","volume":"19","author":"SA Hollingworth","year":"2010","unstructured":"Hollingworth SA, Siskind DJ. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf. 2010;19(3):280\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"3811_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jclinepi.2010.02.015","volume":"64","author":"CY Lu","year":"2011","unstructured":"Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol. 2011;64(2):223\u20138.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"3811_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40801-015-0038-1","volume":"2","author":"D Goeman","year":"2015","unstructured":"Goeman D, Harvey K, Lee CY, Petrie N, Beanland C, Culhane C, Koch S. How prolific is psychotropic medicines use in people with dementia in Australia within the community setting? A retrospective analysis. Drugs Real World Outcomes. 2015;2(3):289\u201398.","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"3811_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/jgs.12210","volume":"61","author":"GB Rattinger","year":"2013","unstructured":"Rattinger GB, Burcu M, Dutcher SK, Chhabra PT, Rosenberg PB, Simoni-Wastila L, Franey CS, Walker LD, Zuckerman IH. Pharmacotherapeutic management of dementia across settings of care. J Am Geriatr Soc. 2013;61(5):723\u201333.","journal-title":"J Am Geriatr Soc"},{"key":"3811_CR34","volume-title":"Osteoporosis costing all Australian: a new burden of disease analysis-2012 to 2022","author":"JJ Watts","year":"2013","unstructured":"Watts JJ, Abimanyi-Ochom J, Sanders KM. Osteoporosis costing all Australian: a new burden of disease analysis-2012 to 2022; 2013."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3811-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T19:18:56Z","timestamp":1577560736000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3811-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3811"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3811-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The New South Wales Population and Health Services Ethics Committee (2013\/11\/494) approved relevant components of this study, including a waver of consent. Data access was granted by the Department of Human Services (MI5250).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A waiver of consent was granted for this project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1009"}}